These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24833241)

  • 21. Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling.
    Agrawal S; Maity S; AlRaawi Z; Al-Ameer M; Kumar TKS
    Curr Drug Targets; 2021; 22(2):214-240. PubMed ID: 33045958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast growth factor receptors in breast cancer: expression, downstream effects, and possible drug targets.
    Tenhagen M; van Diest PJ; Ivanova IA; van der Wall E; van der Groep P
    Endocr Relat Cancer; 2012 Aug; 19(4):R115-29. PubMed ID: 22508544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights into the role of heparan sulphate in fibroblast growth factor signalling.
    Harmer NJ
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):442-5. PubMed ID: 16709182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the fibroblast growth factor receptor family in cancer.
    Hallinan N; Finn S; Cuffe S; Rafee S; O'Byrne K; Gately K
    Cancer Treat Rev; 2016 May; 46():51-62. PubMed ID: 27109926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting FGFR pathway in breast cancer.
    Perez-Garcia J; Muñoz-Couselo E; Soberino J; Racca F; Cortes J
    Breast; 2018 Feb; 37():126-133. PubMed ID: 29156384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FGFR a promising druggable target in cancer: Molecular biology and new drugs.
    Porta R; Borea R; Coelho A; Khan S; Araújo A; Reclusa P; Franchina T; Van Der Steen N; Van Dam P; Ferri J; Sirera R; Naing A; Hong D; Rolfo C
    Crit Rev Oncol Hematol; 2017 May; 113():256-267. PubMed ID: 28427515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular signaling by fibroblast growth factor receptors.
    Eswarakumar VP; Lax I; Schlessinger J
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):139-49. PubMed ID: 15863030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of fibroblast growth factors and their receptors in prostate cancer.
    Kwabi-Addo B; Ozen M; Ittmann M
    Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGFR signaling and endocrine resistance in breast cancer: Challenges for the clinical development of FGFR inhibitors.
    Servetto A; Formisano L; Arteaga CL
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188595. PubMed ID: 34303787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Future applications of FGF/FGFR inhibitors in cancer.
    Ghedini GC; Ronca R; Presta M; Giacomini A
    Expert Rev Anticancer Ther; 2018 Sep; 18(9):861-872. PubMed ID: 29936878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of fibroblast growth factors in tumor growth.
    Korc M; Friesel RE
    Curr Cancer Drug Targets; 2009 Aug; 9(5):639-51. PubMed ID: 19508171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis.
    Ye T; Wei X; Yin T; Xia Y; Li D; Shao B; Song X; He S; Luo M; Gao X; He Z; Luo C; Xiong Y; Wang N; Zeng J; Zhao L; Shen G; Xie Y; Yu L; Wei Y
    Breast Cancer Res Treat; 2014 Feb; 143(3):435-46. PubMed ID: 24398778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the fibroblast growth factor receptor (FGFR) signalling network with heparin as coreceptor: evidence for the expansion of the core FGFR signalling network.
    Xu R; Rudd TR; Hughes AJ; Siligardi G; Fernig DG; Yates EA
    FEBS J; 2013 May; 280(10):2260-70. PubMed ID: 23441759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
    Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
    Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.
    Giacomini A; Chiodelli P; Matarazzo S; Rusnati M; Presta M; Ronca R
    Pharmacol Res; 2016 May; 107():172-185. PubMed ID: 27013279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction.
    Carter EP; Fearon AE; Grose RP
    Trends Cell Biol; 2015 Apr; 25(4):221-33. PubMed ID: 25467007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticancer molecules targeting fibroblast growth factor receptors.
    Liang G; Liu Z; Wu J; Cai Y; Li X
    Trends Pharmacol Sci; 2012 Oct; 33(10):531-41. PubMed ID: 22884522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Insights in the Interaction of FGF/FGFR and Steroid Receptor Signaling in Breast Cancer.
    Pérez Piñero C; Giulianelli S; Lamb CA; Lanari C
    Endocrinology; 2022 Feb; 163(2):. PubMed ID: 34977930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy.
    Heinzle C; Sutterlüty H; Grusch M; Grasl-Kraupp B; Berger W; Marian B
    Expert Opin Ther Targets; 2011 Jul; 15(7):829-46. PubMed ID: 21375471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments and advances of FGFR as a potential target in cancer.
    Xue WJ; Li MT; Chen L; Sun LP; Li YY
    Future Med Chem; 2018 Sep; 10(17):2109-2126. PubMed ID: 30066580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.